You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Addressing the Challenges of Tuberculosis: A Brief Historical Account
|
|---|---|
| Published in |
Frontiers in Pharmacology, September 2017
|
| DOI | 10.3389/fphar.2017.00689 |
| Pubmed ID | |
| Authors |
Hussam W. Al-Humadi, Rafal J. Al-Saigh, Ahmed W. Al-Humadi |
| Abstract |
Tuberculosis (TB) is a highly contagious disease that still poses a threat to human health. Mycobacterium tuberculosis (MTB), the pathogen responsible for TB, uses diverse ways in order to survive in a variety of host lesions and to subsequently evade immune surveillance; as a result, fighting TB and its associated multidrug resistance has been an ongoing challenge. The aim of this review article is to summarize the historical sequence of drug development and use in the fight against TB, with a particular emphasis on the decades between World War II and the dawn of the twenty first century (2000). |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 25% |
| Switzerland | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 120 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 21 | 18% |
| Student > Ph. D. Student | 16 | 13% |
| Student > Bachelor | 10 | 8% |
| Student > Postgraduate | 9 | 8% |
| Student > Doctoral Student | 6 | 5% |
| Other | 14 | 12% |
| Unknown | 44 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 14% |
| Biochemistry, Genetics and Molecular Biology | 11 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 9% |
| Nursing and Health Professions | 8 | 7% |
| Immunology and Microbiology | 8 | 7% |
| Other | 17 | 14% |
| Unknown | 48 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 November 2017.
All research outputs
#6,487,734
of 23,003,906 outputs
Outputs from Frontiers in Pharmacology
#2,699
of 16,311 outputs
Outputs of similar age
#105,058
of 320,414 outputs
Outputs of similar age from Frontiers in Pharmacology
#43
of 278 outputs
Altmetric has tracked 23,003,906 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 16,311 research outputs from this source. They receive a mean Attention Score of 5.0. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,414 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 278 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.